Under the deal, Sanofi will start a tender offer of $15.50 a share in cash to acquire all of Dynavax, which has a hepatitis B shot approved in the U.S. and a candidate for a shingles vaccine under ...
Disease combinations are often unique – anonymization of health data is therefore particularly complex. An interview on ...
Successfully completed its public listing on the NYSE American, expanding access to capital and increasing visibility with ...
The Romanian executive has released a draft emergency ordinance that provides for the creation of the official platform ...
Global blockbuster immune-oncology products now face major patent expirations before 2030 pharmaceutical companies are either actively developing or acquiring next-generation assets that are highly ...
The number of AI inference chip startups in the world is gross – literally gross, as in a dozen dozens. But there is only one ...
Motocaddy designs and sells some of the finest electric caddies on the planet. With this new rangefinder, Motocaddy is likely ...
Seipasa’s partnership with Valent BioSciences accelerates U.S. biostimulant adoption through precision science, regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback